IP Library › Granted Patent US 8,221,762
Granted Patent B2
US 8,221,762 · App. 12/507,163 · Granted Jul 17, 2012

Naturally processed measles virus peptides from class II HLA molecules

Assignee: Mayo Foundation for Medical Education and Research
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,221,762
App. No.
12/507,163
Granted
Jul 17, 2012
Kind
B2
Abstract

A preparation of peptides eluted from class II HLA molecules is disclosed. Methods of decreasing measles infections comprising inoculating human patients with a vaccine comprising one or more of the peptides and methods of diagnosing measles infections or immunity comprising analyzing human patients for the presence of one or more of the peptides or antibodies to the peptide(s) are also disclosed.

Claims (2)

1. A method of inducing (or enhancing) an immune response to measles virus comprising inoculating a human patient with a combination of peptides consisting of SEQ ID NOS: 1 and 13.

2. The method of claim 1 further comprising inoculating the human patient with a peptide selected from the group consisting of SEQ ID NO:2-12.

Assignments (1)
CONFIRMATORY LICENSE Recorded Feb 3, 2010
From: MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 023893/0886 →
Continuity (4)
Continuation 11266957 · Nov 4, 2005
Continuation In Part 11116682 · Apr 28, 2005
Provisional Application 60566899 · Apr 30, 2004
Related Publication 20100119536A1 · May 13, 2010